Síndrome cardiopulmonar por hantavírus

Centers for Disease Control and Prevention. Clinician brief: hantavirus pulmonary syndrome (HPS)​. May 2026 [internet publication].Texto completo

Ulloa-Morrison R, Pavez N, Parra E, et al. Critical care management of hantavirus cardiopulmonary syndrome. A narrative review. J Crit Care. 2024 Dec;84:154867.Texto completo  Resumo

1. Vial PA, Ferrés M, Vial C, et al. Hantavirus in humans: a review of clinical aspects and management. Lancet Infect Dis. 2023 Sep;23(9):e371-82. Resumo

2. Vapalahti O, Mustonen J, Lundkvist A, et al. Hantavirus infections in Europe. Lancet Infect Dis. 2003 Oct;3(10):653-61. Resumo

3. Kuhn JH, Schmaljohn CS. A brief history of bunyaviral family Hantaviridae. Diseases. 2023 Feb 28;11(1):38.Texto completo  Resumo

4. Figueiredo LT, Souza WM, Ferrés M, et al. Hantaviruses and cardiopulmonary syndrome in South America. Virus Res. 2014 Jul 17;187:43-54. Resumo

5. Chapman LE, Ellis BA, Koster FT, et al. Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome. Clin Infect Dis. 2002 Feb 1;34(3):293-304.Texto completo  Resumo

6. Centers for Disease Control and Prevention. ​2026 multi-country hantavirus cluster linked to cruise ship. May 2026 [internet publication].Texto completo

7. Afzal S, Ali L, Batool A, et al. Hantavirus: an overview and advancements in therapeutic approaches for infection. Front Microbiol. 2023 Oct 12;14:1233433.Texto completo  Resumo

8. Miller MJ. Viral taxonomy. Clin Infect Dis. 1999 Oct;29(4):731-3.Texto completo  Resumo

9. McCaughey C, Hart CA. Hantaviruses. J Med Microbiol. 2000 Jul;49(7):587-99.Texto completo  Resumo

10. Peters CJ, Khan AS. Hantavirus pulmonary syndrome: the new American hemorrhagic fever. Clin Infect Dis. 2002 May 1;34(9):1224-31.Texto completo  Resumo

11. Hjelle B, Goade D, Torrez-Martinez N, et al. Hantavirus pulmonary syndrome, renal insufficiency and myositis associated with infection by Bayou hantavirus. Clin Infect Dis. 1996 Sep;23(3):495-500. Resumo

12. Khan AS, Gaviria M, Rollin PE, et al. Hantavirus pulmonary syndrome in Florida: association with the newly identified Black Creek Canal virus. Am J Med. 1996 Jan;100(1):46-8. Resumo

13. Centers for Disease Control and Prevention. Reported cases of hantavirus disease. Apr 2026 [internet publication].Texto completo

14. Kerins JL, Koske SE, Kazmierczak J, et al. Outbreak of Seoul virus among rats and rat owners - United States and Canada, 2017. Can Commun Dis Rep. 2018 Feb 1;44(2):71-4.Texto completo  Resumo

15. Abbott KD, Ksiazek TG, Mills JN. Long-term hantavirus persistence in rodent populations in central Arizona. Emerg Infect Dis. 1999 Jan-Feb;5(1):102-12.Texto completo  Resumo

16. Butler JC, Peters CJ. Hantaviruses and hantavirus pulmonary syndrome. Clin Infect Dis. 1994 Sep;19(3):387-94;quiz 395. Resumo

17. Núñez JJ, Fritz CL, Knust B, et al. Hantavirus infections among overnight visitors to Yosemite National Park, California, USA, 2012. Emerg Infect Dis. 2014 Mar;20(3):386-93.Texto completo  Resumo

18. World Health Organization. Hantavirus pulmonary syndrome - Argentine Republic. Jan 2019 [internet publication].Texto completo

19. Kofman A, Eggers P, Kjemtrup A, et al. Notes from the field: contact tracing investigation after first case of Andes virus in the United States - Delaware, February 2018. MMWR Morb Mortal Wkly Rep. 2018 Oct 19;67(41):1162-3.Texto completo  Resumo

20. World Health Organization.​ Hantavirus outbreak linked to cruise ship travel, Multi-locations. Jul 2026 [internet publication].Texto completo

21. van den Berg OE, UKHSA ANDV Team, Severi E, et al. Andes virus outbreak linked to expedition cruise ship travel, multi-country investigation and response, April to June 2026. Euro Surveill. 2026 Jun;31(24):2600477.Texto completo  Resumo

22. Hjelle B, Glass GE. Outbreak of hantavirus infection in the Four Corners region of the United States in the wake of the 1997-1998 El Nino-southern oscillation. J Infect Dis. 2000 May;181(5):1569-73.Texto completo  Resumo

23. Calisher CH, Mills JN, Root JJ, et al. Hantaviruses: etiologic agents of rare but potentially life-threatening zoonotic diseases. J Am Vet Med Assoc. 2003 Jan 15;222(2):163-6. Resumo

24. ​UK Health Security Agency. Hantavirus: human-to-human infection transmission parameters. Jun 2026 [internet publication].Texto completo

25. Howard MJ, Doyle TJ, Koster FT, et al. Hantavirus pulmonary syndrome in pregnancy. Clin Infect Dis. 1999 Dec;29(6):1538-44.Texto completo  Resumo

26. Medina RA, Torres-Perez F, Galeno H, et al. Ecology, genetic diversity, and phylogeographic structure of andes virus in humans and rodents in Chile. J Virol. 2009 Mar;83(6):2446-59.Texto completo  Resumo

27. Martinez VP, Bellomo C, San Juan J, et al. Person-to-person transmission of Andes virus. Emerg Infect Dis. 2005 Dec;11(12):1848-53.Texto completo  Resumo

28. Martinez-Valdebenito C, Calvo M, Vial C, et al. Person-to-person household and nosocomial transmission of andes hantavirus, Southern Chile, 2011. Emerg Infect Dis. 2014 Oct;20(10):1629-36.Texto completo  Resumo

29. Ferres M, Vial P, Marco C, et al. Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in Chile. J Infect Dis. 2007 Jun 1;195(11):1563-71.Texto completo  Resumo

30. Kim JY. 2026 Cruise ship-associated andes hantavirus outbreak and public health response. Public Health Wkly Rep. 2026;19(26):1069-91.Texto completo  Resumo

31. Godoy P, Marsac D, Stefas E, et al. Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome. J Virol. 2009 May;83(10):5046-55.Texto completo  Resumo

32. Toledo J, Haby MM, Reveiz L, et al. Evidence for human-to-human transmission of hantavirus: a systematic review. J Infect Dis. 2022 Oct 17;226(8):1362-71.Texto completo  Resumo

33. Kakoullis L, Carr ER, Baissary J, et al. Andes virus exposure and nosocomial transmission events to healthcare personnel: a systematic review. Clin Infect Dis. 29 Jun 2026 [Epub ahead of print].Texto completo  Resumo

34. Castillo C, Villagra E, Sanhueza L, et al. Prevalence of antibodies to hantavirus among family and health care worker contacts of persons with hantavirus cardiopulmonary syndrome: lack of evidence for nosocomial transmission of Andes virus to health care workers in Chile. Am J Trop Med Hyg. 2004 Mar;70(3):302-4.Texto completo  Resumo

35. Fritz CL, Young JC. Estimated incubation period for hantavirus pulmonary syndrome. Am J Trop Med Hyg. 2001 Nov;65(5):403. Resumo

36. St Jeor SC. Three-week incubation period for hantavirus infection. Pediatr Infect Dis J. 2004 Oct;23(10):974-5. Resumo

37. Borges AA, Campos GM, Moreli ML, et al. Hantavirus cardiopulmonary syndrome: immune response and pathogenesis. Microbes Infect. 2006 Jul;8(8):2324-30. Resumo

38. Bharadwaj M, Nofchissey R, Goade D, et al. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J Infect Dis. 2000 Jul;182(1):43-8.Texto completo  Resumo

39. Green W, Feddersen R, Yousef O, et al. Tissue distribution of hantavirus antigen in naturally infected humans and deer mice. J Infect Dis. 1998 Jun;177(6):1696-700. Resumo

40. Zavasky DM, Hjelle B, Peterson MC, et al. Acute infection with Sin Nombre hantavirus without pulmonary edema. Clin Infect Dis. 1999 Sep;29(3):664-6. Resumo

41. Maes P, Clement J, Gavrilovskaya I, et al. Hantaviruses: immunology, treatment, and prevention. Viral Immunol. 2004;17(4):481-97. Resumo

42. Mori M, Rothman AL, Kurane I, et al. High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis. 1999 Feb;179(2):295-302.Texto completo  Resumo

43. Gavrilovskaya IN, Gorbunova EE, Mackow ER. Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells. J Virol. 2010 May;84(9):4832-9.Texto completo  Resumo

44. Steinberg BE, Goldenberg NM, Lee WL. Do viral infections mimic bacterial sepsis? The role of microvascular permeability: a review of mechanisms and methods. Antiviral Res. 2012 Jan;93(1):2-15. Resumo

45. Geimonen E, LaMonica R, Springer K, et al. Hantavirus pulmonary syndrome-associated hantaviruses contain conserved and functional ITAM signaling elements. J Virol. 2003 Jan;77(2):1638-43.Texto completo  Resumo

46. Borges AA, Figueiredo LT. Mechanisms of shock in hantavirus pulmonary syndrome. Curr Opin Infect Dis. 2008 Jun;21(3):293-7. Resumo

47. Saggioro FP, Rossi MA, Duarte MIS, et al. Hantavirus infection induces a typical myocarditis that may be responsible for myocardial depression and shock in hantavirus pulmonary syndrome. J Infect Dis. 2007 May 15;195(10):1541-9.Texto completo  Resumo

48. Raftery MJ, Lalwani P, Krautkrӓmer E, et al. β2 integrin mediates hantavirus-induced release of neutrophil extracellular traps. J Exp Med. 2014 Jun 30;211(7):1485-97.Texto completo  Resumo

49. ​Centers for Disease Control and Prevention. Hantavirus prevention. May 2024 [internet publication].Texto completo

50. Brocato RL, Hooper JW. Progress on the prevention and treatment of hantavirus disease. Viruses. 2019 Jul 4;11(7):610.Texto completo  Resumo

51. Jonsson CB, Hooper J, Mertz G. Treatment of hantavirus pulmonary syndrome. Antiviral Res. 2008 Apr;78(1):162-9.Texto completo  Resumo

52. UK Health Security Agency. Hantavirus: vaccine effectiveness following Andes virus exposure. Jun 2026 [internet publication].Texto completo

53. Paulsen GC, Frenck R Jr, Tomashek KM, et al. Safety and immunogenicity of an Andes virus DNA vaccine by needle-free injection: a randomized, controlled phase 1 study. J Infect Dis. 2024 Jan 12;229(1):30-8.Texto completo  Resumo

54. Meyer M, Kuzmin IV, Dews EA, et al. Single-dose mRNA vaccines against Andes hantavirus. Lancet. 2026 Jun 20;407(10547):2495-7. Resumo

55. ​Centers for Disease Control and Prevention. Appendix A: type and duration of precautions recommended for selected infections and conditions. Feb 2025 [internet publication].Texto completo

56. ​World Health Organization. Standard precautions for the prevention and control of infections: aide-memoire. Jun 2022 [internet publication].Texto completo

57. UK Health Security Agency. Andes hantavirus: epidemiology, outbreaks and guidance. Jun 2026 [internet publication].Texto completo

58. Mertz GJ, Hjelle B, Crowley M, et al. Diagnosis and treatment of new world hantavirus infections. Curr Opin Infect Dis. 2006 Oct;19(5):437-42. Resumo

59. Ferrer JF, Jonsson CB, Esteban E, et al. High prevalence of hantavirus infection in Indian communities of the Paraguayan and Argentinean Gran Chaco. Am J Trop Med Hyg. 1998 Sep;59(3):438-44.Texto completo  Resumo

60. Campos GM, Moro de Sousa RL, Badra SJ, et al. Serological survey of hantavirus in Jardinopolis County, Brazil. J Med Virol. 2003 Nov;71(3):417-22. Resumo

61. Muñoz-Zanzi C, Saavedra F, Otth C, et al. Serological evidence of hantavirus infection in apparently healthy people from rural and slum communities in southern Chile. Viruses. 2015 Apr 17;7(4):2006-13.Texto completo  Resumo

62. Smith HM, Reporter R, Rood MP, et al. Prevalence study of antibody to ratborne pathogens and other agents among patients using a free clinic in downtown Los Angeles. J Infect Dis. 2002;186:1673-1676. Resumo

63. Yanagihara R. Hantavirus infection in the United States: epizootiology and epidemiology. Rev Infect Dis. 1990;12:449-457. Resumo

64. Chang B, Crowley M, Campen M, et al. Hantavirus cardiopulmonary syndrome. Semin Respir Crit Care Med. 2007 Apr;28(2):193-200. Resumo

65. Koster F, Foucar K, Hjelle B, et al. Rapid presumptive diagnosis of hantavirus cardiopulmonary syndrome by peripheral blood smear review. Am J Clin Pathol. 2001 Nov;116(5):665-72.Texto completo  Resumo

66. Centers for Disease Control and Prevention. Clinician brief: hantavirus pulmonary syndrome (HPS)​. May 2026 [internet publication].Texto completo

67. World Health Organization. Hantavirus - fact sheet​. May 2026 [internet publication].Texto completo

68. World Health Organization. ​Laboratory testing of Andes virus (Orthohantavirus andesense) infection: interim guidance, 15 May 2026. May 2026 [internet publication].Texto completo

69. Centers for Disease Control and Prevention. Hantavirus pulmonary syndrome (HPS) 2015 case definition. Apr 2021 [internet publication].Texto completo

70. Vial C, Martinez-Valdebenito C, Rios S, et al. Molecular method for the detection of Andes hantavirus infection: validation for clinical diagnostics. Diagn Microbiol Infect Dis. 2016 Jan;84(1):36-9.Texto completo  Resumo

71. Centers for Disease Control and Prevention. About hantavirus​. May 2024 [internet publication].Texto completo

72. Machado AM, Figueiredo GG, Dos Santos Junior GS, et al. Laboratory diagnosis of human hantavirus infection: novel insights and future potential. Future Virol. 2009;4:383-9.

73. Crowley MR, Katz RW, Kessler R, et al. Successful treatment of adults with severe Hantavirus pulmonary syndrome with extracorporeal membrane oxygenation. Crit Care Med. 1998 Feb;26(2):409-14. [Erratum in: Crit Care Med. 1998 Apr;26(4):806.] Resumo

74. Ulloa-Morrison R, Pavez N, Parra E, et al. Critical care management of hantavirus cardiopulmonary syndrome. A narrative review. J Crit Care. 2024 Dec;84:154867.Texto completo  Resumo

75. Hallin GW, Simpson SQ, Crowell RE, et al. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med. 1996 Feb;24(2):252-8. Resumo

76. Nolte KB, Feddersen RM, Foucar K, et al. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol. 1995 Jan;26(1):110-20. Resumo

77. Boroja M, Barrie JR, Raymond GS. Radiographic findings in 20 patients with Hantavirus pulmonary syndrome correlated with clinical outcome. AJR Am J Roentgenol. 2002 Jan;178(1):159-63.Texto completo  Resumo

78. de Oliveira RC, Guterres A, Teixeira BR, et al. A fatal hantavirus pulmonary syndrome misdiagnosed as dengue: an investigation into the first reported case in Rio de Janeiro State, Brazil. Am J Trop Med Hyg. 2017 Jul;97(1):125-9.Texto completo  Resumo

79. Ketai LH, Kelsey CA, Jordon K, et al. Distinguishing hantavirus pulmonary syndrome from acute respiratory distress syndrome by chest radiography: are there different radiographic manifestations of increased alveolar permeability? J Thorac Imaging. 1998 Jul;13(3):172-7. Resumo

80. World Health Organization. Hantavirus outbreak toolbox. May 2026 [internet publication].Texto completo

81. Wernly JA, Dietl CA, Tabe CE, et al. Extracorporeal membrane oxygenation support improves survival of patients with Hantavirus cardiopulmonary syndrome refractory to medical treatment. Eur J Cardiothorac Surg. 2011 Dec;40(6):1334-40.Texto completo  Resumo

82. Moore SA, Dietl CA, Coleman DM. Extracorporeal life support during pregnancy. J Thorac Cardiovasc Surg. 2016 Apr;151(4):1154-60. Resumo

83. Safronetz D, Falzarano D, Scott DP, et al. Antiviral efficacy of favipiravir against two prominent etiological agents of hantavirus pulmonary syndrome. Antimicrob Agents Chemother. 2013 Oct;57(10):4673-80.Texto completo  Resumo

84. Munir N, Jahangeer M, Hussain S, et al. Hantavirus diseases pathophysiology, their diagnostic strategies and therapeutic approaches: A review. Clin Exp Pharmacol Physiol. 2021 Jan;48(1):20-34. Resumo

85. Mertz GJ, Miedzinski L, Goade D, et al. Placebo controlled, double blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis. 2004 Nov 1;39(9):1307-13.Texto completo  Resumo

86. Chapman LE, Mertz GJ, Peters CJ, et al. Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open label experience. Ribavirin Study Group. Antivir Ther. 1999;4(4):211-9. Resumo

87. Vial PA, Valdivieso F, Calvo M et al. A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virus. Antivir Ther. 2015;20(4):377-86. Resumo

88. Tortosa F, Santamaría G, Bustamante R, et al. Use of tocilizumab for severe hantavirus pulmonary syndrome: a MEURI case series with contextual comparisons. Lancet Infect Dis. 3 Jun 2026 [Epub ahead of print]. Resumo

89. Estébanez M, Sacristán MS, Forte TM, et al. First reported case of Andes hantavirus cardiopulmonary syndrome treated with a combination of favipiravir, ribavirin, icatibant and baricitinib. Clin Microbiol Infect. 30 May 2026 [Epub ahead of print].Texto completo  Resumo

90. Vial PA, Valdivieso F, Ferres M, et al. High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial. Clin Infect Dis. 2013 Oct;57(7):943-51.Texto completo  Resumo

91. Jacob AT, Ziegler BM, Farha SM, et al. Sin Nombre virus and the emergence of other hantaviruses: a review of the biology, ecology, and disease of a zoonotic pathogen. Biology (Basel). 2023 Nov 9;12(11):1413.Texto completo  Resumo

92. ​​Centers for Disease Control and Prevention. Morbidity and mortality weekly report: hantavirus pulmonary syndrome -United States, 1995 and 1996. Apr 1996 [internet publication].Texto completo

93. Gracia F, Armien B, Simpson SQ, et al. Convalescent pulmonary dysfunction following hantavirus pulmonary syndrome in Panama and the United States. Lung. 2010 Oct;188(5):387-91.Texto completo  Resumo

94. Nath A. Neurological manifestations of hantavirus infection: a review. JAMA Neurol. 2026 Jul 14 [Epub ahead of print].Texto completo  Resumo

95. Pergam SA, Schmidt DW, Nofchissey RA, et al. Potential renal sequelae in survivors of hantavirus cardiopulmonary syndrome. Am J Trop Med Hyg. 2009;80:279-285. Resumo